1. Golden SH, Robinson KA, Saldanha I, et al. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009; 94: 1853–1878.
2. Altomare M, La Vignera S, Asero P, et al. High prevalence of thyroid dysfunction in pregnant women. J Endocrinol Invest. 2013; 36: 407–411.
3. Zimmermann MB. Iodine deficiency. Endocr Rev. 2009; 30: 376–408.
4. Leung AM, Pearce EN, Braverman LE. Iodine content of prenatal multivitamins in the United States. N Engl J Med. 2009; 360: 939–940.
5. Leung AM, Pearce EN, Braverman LE. Sufficient iodine intake during pregnancy: just do it. Thyroid. 2013; 23: 7–8.
6. Caldwell KL, Makhmudov A, Ely E, et al. Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008. Thyroid. 2011; 21: 419–422.
7. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012; 33: 378–455.
8. Andra SS, Makris KC. Thyroid disrupting chemicals in plastic additives and thyroid health. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012; 30: 107–151.
9. Massart F, Ferrara P, Saggese G. Environmental thyroid disruptors and human endocrine health In: Springer D, ed. A New Look at Hypothyroidism. 2012; .New York: InTech;
10. Kalantaridou SN, Zoumakis E, Makrigiannakis A, et al. The role of corticotropin-releasing hormone in blastocyst implantation and early fetal immunotolerance. Horm Metab Res. 2007; 39: 474–477.
11. Vrekoussis T, Kalantaridou SN, Mastorakos G, et al. The role of stress in female reproduction and pregnancy: an update. Ann N Y Acad Sci. 2010; 1205: 69–75.
12. Yuen KC, Chong LE, Koch CA. Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management. Endocrine. 2013;Feb 2 [Epub ahead of print]
13. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97: 2543–2565.
14. Stagnaro-Green A. Optimal care of the pregnant woman with thyroid disease. J Clin Endocrinol Metab. 2012; 97: 2619–2622.
15. Stagnaro-Green A, Pearce E. Thyroid disorders in pregnancy. Nat Rev Endocrinol. 2012; 8: 650–658.
16. Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012; 97: 334–342.
17. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011; 21: 1081–1125.
18. Soldin OP. When thyroidologists agree to disagree: comments on the 2012 Endocrine Society pregnancy and thyroid disease clinical practice guideline. J Clin Endocrinol Metab. 2012; 97: 2632–2635.
19. Negro R. Thyroid dysfunction and pregnancy: where are we five years later? J Clin Endocrinol Metab. 2012; 97: 2629–2631.
20. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012; 22: 1200–1235.
21. Midgley JE, Hoermann R. Measurement of total rather than free thyroxine in pregnancy: the diagnostic implications. Thyroid. 2013; 23: 259–261.
22. Velkeniers B, Van Meerhaeghe A, Poppe K, et al. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 2013; 19: 251–258.
23. Hackmon R, Blichowski M, Koren G. The safety of methimazole and propylthiouracil in pregnancy: a systematic review. J Obstet Gynaecol Can. 2012; 34: 1077–1086.
24. Brent GA. The debate over thyroid-function screening in pregnancy. N Engl J Med. 2012; 366: 562–563.
25. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012; 366: 493–501.
26. Sang Z, Wei W, Zhao N, et al. Thyroid dysfunction during late gestation is associated with excessive iodine intake in pregnant women. J Clin Endocrinol Metab. 2012; 97: E13631–E13639.
27. Wilson KL, Casey BM, McIntire DD, et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012; 119: 315–320.
28. Wang QW, Yu B, Huang RP, et al. Assessment of thyroid function during pregnancy: the advantage of self-sequential longitudinal reference intervals. Arch Med Sci. 2011; 7: 679–678.
29. Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med. 1994; 331: 1072–1078.
31. Ballabio M, Poshychinda M, Ekins RP. Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab. 1991; 73: 824–831.
32. Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 2008; 20: 784–794.
33. Auso E, Lavado-Autric R, Cuevas E, et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology. 2004; 145: 4037–4047.
34. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid. 2011; 21: 5–11.
35. Glinoer D, Spencer CA. Serum TSH determinations in pregnancy: how, when and why? Nat Rev Endocrinol. 2010; 6: 526–529.
36. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341: 549–555.
37. Brucker-Davis F, Ferrari P, Gal J, et al. Iodine status has no impact on thyroid function in early healthy pregnancy. J Thyroid Res. 2012; : 168764
38. Chandra AK, Singh LH, Ghosh S. Role of bamboo shoot in the pathogenesis of endemic goiter in Manipur, North East India. Endocr Pract. 2013; 19: 36–45.
39. Pop VJ, Brouwers EP, Vader HL, et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol. 2003; 59: 282–288.
40. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006; 91: 2587–2591.
41. Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010; 95: E44–E48.
42. Breese McCoy SJ. Postpartum depression: an essential overview for the practitioner. South Med J. 2011; 104: 128–132.
43. Aslam M, Inayat M. Fetal and neonatal Graves disease: a case report and review of the literature. South Med J. 2008; 101: 840–841.
44. Westphal SA. Hepatotoxicity from propylthiouracil. South Med J. 1994; 87: 943–947.
45. Momotani N, Hisaoka T, Noh J, et al. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves’ disease complicated by pregnancy. J Clin Endocrinol Metab. 1992; 75: 738–744.
46. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab. 2001; 86: 2354–2359.
47. Leboeuf R, Emerick LE, Martorella AJ, et al. Impact of pregnancy on serum thyroglobulin and detection of recurrent disease shortly after delivery in thyroid cancer survivors. Thyroid. 2007; 17: 543–547.